The importance of drug-transporting P-glycoproteins in toxicology

Toxicology Letters

Volumn 120, Issue 1-3, 2001, Pages 31-41

  Van Tellingen, Olaf ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Knockout mice; Multidrug resistance; P Glycoprotein; Protective function

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; XENOBIOTIC AGENT;

BILIARY EXCRETION; BLOOD BRAIN BARRIER; CELL MEMBRANE; CELL PROTECTION; CONFERENCE PAPER; DRUG CLEARANCE; DRUG EXCRETION; DRUG EXPOSURE; DRUG TRANSPORT; DRUG UPTAKE; ENTEROHEPATIC CIRCULATION; GASTROINTESTINAL TRACT; INTRAHEPATIC BILE DUCT; KNOCKOUT MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYSTEMIC CIRCULATION; TOXICOLOGY; TUMOR CELL;

ANIMALS; BRAIN; DRUG RESISTANCE, MULTIPLE; HUMANS; INTESTINES; MICE; MICE, KNOCKOUT; P-GLYCOPROTEIN; TOXICOLOGY;

EID: 0035977897     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00304-6     Document Type: Conference Paper

References (77)

1. Unknotting the complexities of multidrug resistance: The involvement of DNA topoisomerases in drug action and resistance
2. Cellular resistance to actinomycin D in chinese hamster cells in vitro: Cross resistance radioautographic and cytogenetic studies
3. New physiological functions for drug-transporting P-glycoproteins?
4. Clinical relevance of transmembrane efflux as a mechanism of multidrug resistance
5. Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells
6. Expression and activity of P-glycoprotein, a multidrug efflux pump in hematopoietic stem cells
7. In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity
8. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug resistant human cells
9. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
10. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells
11. Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
12. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
13. Genetics of multidrug resistance: Relationship of a cloned gene to the complete multidrug resistance phenotype
14. The three mouse multidrug resistance (mdr) genes are expressed in a tissue specific manner in normal mouse tissues
15. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979
16. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities
17. The biochemistry of P-glycoprotein-mediated multidrug resistance
18. Pharmacology of drugs that alter multidrug resistance in cancer
19. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance
20. Multidrug resistance
21. How cancer cells evade chemotherapy: 16Th Richard and Hinda Rosenthal foundation award lecture
22. Biochemistry of multidrug resistance mediated by the multidrug transporter
23. Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins
24. Isolation and characterization of DNA sequences amplified in multidrug resistant hamster cells
25. Cloning and characterization of a second member of the mouse mdr gene family
26. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia
27. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative
28. Multiple physiological functions for multidrug transporter P-glycoprotein?
29. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug
30. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
31. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cells
32. Multidrug resistance: Clinical relevance in solid tumours and strategies for circumvention
33. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
34. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice
35. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter
36. Multidrug resistance in leukemia
37. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA
38. The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein
39. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr1a P-glycoprotein
40. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833
41. Use of fluorescent dyes as molecular probes for the study of multidrug resistance
42. Enhanced transepithelial flux of cimetidine by Madin-Darby canine kidney cells overexpressing human P-glycoprotein
43. Physical mapping, amplfication and overexpression of the mouse mdr gene family in multidrug resistant cells
44. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter
45. Isolation of human mdr DNA sequences amplified in multidrug resistant KB carcinoma cells
46. Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP
47. Human P-glycoprotein transports cyclosporin A and FK506
48. Interaction of bioactive hydrophobic peptides with the human multidrug transporter
49. P-glycoprotein, a gatekeeper in the blood-brain barrier
50. Multidrug resistance mediated by P-glycoproteins
51. Disruption of the mouse mdr1a p-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
52. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
53. Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes
54. A general pattern for substrate recognition by P- glycoprotein
55. Peptide transport by the multidrug resistance pump
56. The P-glycoprotein efflux pump: How does it transport drugs?
57. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
58. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete abscence of phospholipid from the bile and to liver desease
59. Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption
60. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure
61. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice
62. MDR3 P-glycoprotein, a phospholipid translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping
63. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
64. Tissue distribution of P-glycoprotein encoded by a multidrug resistant gene as revealed by a monoclonal antibody, MRK16
65. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1)
66. Cellular localization of the multidrug resistance gene product in normal human tissues
67. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
68. Expression of full-length DNA for the human MDR1 gene confers resistance to colchicine, doxorubicin and vinblastine
69. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone
70. How does P-glycoprotein recognize its substrates?
71. Altered Pharmacokinetics of vinblastine in mdr1a P-glycoprotein deficient mice
72. Comparative pharmacokinetics of vinblastine after a 96- hour continuous infusion in wild-type mice and mice lacking mdr1a P-glycoprotein
73. Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein
74. The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice
75. Multidrug resistance
76. Tissue disposition, excretion and metabolism of vinblastine in mice as determined by high-performance liquid chromatography
77. Disruption of mdr1a p-glycoprotein gene results in dysfunction of blood-inner ear barrier in mice